Neuromodulation therapies and potential treatments for traumatic brain injury

Zhining Zhang

doi:10.1117/12.2660149

6 December 2022 Neuromodulation therapies and potential treatments for traumatic brain injury

Zhining Zhang

Proceedings Volume 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022); 124582J (2022) https://doi.org/10.1117/12.2660149
Event: International Conference on Biomedical and Intelligent Systems, 2022, Chengdu, China

Abstract

Traumatic brain injury (TBI) is a leading cause of death and disability throughout the world. Its primary and secondary damage can lead to impaired neurological function and serious complications such as post-traumatic stress disorder, cognitive or behavioural impairment, epilepsy and neurodegenerative diseases. This article outlines the main mechanisms of secondary brain injury and provides an updated direction for potential neuroprotective treatments. Among other things, current clinical studies suggest that vagus nerve stimulation (VNS) may reduce brain injury after TBI by inhibiting oxidative stress, inflammation and apoptosis, promote recovery of consciousness and cognitive function after experimental TBI, enhance motor and cognitive recovery, reduce brain oedema and inflammation, reduce blood-brain barrier disruption, and confer neuroprotection. In addition, the literature describes deep brain stimulation, gene therapy targeting the combined regeneration of stem cells and biomaterials for TB repair, novel neuroprotective drugs and nanomaterials enabling electrophysiological recording tests and biochemical modulation. Although the data suggest that these potential therapeutic approaches are beneficial for the eventual outcome of TBI, their availability for good use in clinical trials needs to be further explored.

Citation Download Citation

Zhining Zhang "Neuromodulation therapies and potential treatments for traumatic brain injury", Proc. SPIE 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), 124582J (6 December 2022); https://doi.org/10.1117/12.2660149

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available